Pure Global

A Study to Investigate the Safety and Pharmacokinetics of AZD6793 in Healthy Japanese and Chinese Participants - Trial NCT06368440

Access comprehensive clinical trial information for NCT06368440 through Pure Global AI's free database. This Phase 1 trial is sponsored by AstraZeneca and is currently Not yet recruiting. The study focuses on Healthy Participants. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06368440
Phase 1
Not yet recruiting
drug
Trial Details
ClinicalTrials.gov • NCT06368440
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
A Study to Investigate the Safety and Pharmacokinetics of AZD6793 in Healthy Japanese and Chinese Participants
A Single-blind, Randomized, Placebo-controlled Study to Investigate the Safety, Tolerability and Pharmacokinetics of an Oral Suspension of AZD6793 Following Single and Multiple Doses in Japanese and Chinese Healthy Participants

Study Focus

Healthy Participants

AZD6793

Interventional

drug

Sponsor & Location

AstraZeneca

Glendale, United States of America

Timeline & Enrollment

Phase 1

May 15, 2024

Oct 04, 2024

40 participants

Primary Outcome

Part 1 (SAD): Number of Participants with Adverse Events,Part 2 (MAD): Number of Participants with Adverse Events

Summary

The main purpose of this study is to assess the safety, tolerability and pharmacokinetics
 (PK) of oral AZD6793 in healthy Japanese and Chinese participants.

ICD-10 Classifications

Seeking and accepting physical, nutritional and chemical interventions known to be hazardous and harmful
Healthy person accompanying sick person
Routine general health check-up of sports teams
Obesity
Persons with potential health hazards related to communicable diseases

Data Source

ClinicalTrials.gov

NCT06368440

Non-Device Trial